About Conference

In the last few decades, diagnostic and therapeutic advances in Gastrointestinal Cancer have been notable. However, because of contemporary eating and living practices, many fields continue to provide difficulties. To explore more in-depth research findings and recent innovations join us at the “23rd World Congress on Gastrointestinal Cancer” which is scheduled on November 21-22, 2024 at the city of hidden gems Dubai, UAE and share your thoughts on the “Emerging Advances in Gastro Cancer” which is designed as the theme for this Gastro Cancer Conference. Stay united with the Oncology meeting to have a stance on major future innovations in some hot clinical topics in Gastro Cancer, as well as the current pitfalls and the grey zones.

Sessions and Tracks

Track1: Nutrition in Cancer
Track2: Gastrointestinal Disorders
Track3:Gastrointestinal Cancer
Track 4:Gastrointestinal Oncology
Track5: Gastroenterology
Track6: Gastrointestinal Immunology
Track7: Irritable Bowel Syndrome
Track8: Gastrointestinal Pathology
Track9: Clinical Advances in Liver Diseases
Track10: Liver Cirrhosis
Track11: Hepato Radiology
Track12: Digestive Disorders
Track13: Gastroesophageal Reflux Malady
Track14: Microbiota and Diseases
Track15: Liver Diseases and Hepatitis
Track16: Gallbladder and Biliary Tract Diseases
Track17: Gastrointestinal Endoscopy
Track18: Gastrointestinal Pharmacology
Track19: Gastrointestinal Therapeutics
Track20: Neuro Gastroenterology
Track21:Covid-19 and GI Cancer Management

Reasons to attend

Gastro Cancer is a platform that bridges open-access publications and international scientific conferences. It offers participants the opportunity to present their research to globally recognized doctors, scientists, and professors. The conference is particularly beneficial for young researchers seeking to explore, learn, and collaborate. Organized by Conference Series LLC LTD, it features well-organized scientific sessions, plenary lectures, poster presentations, world-class exhibitions, diverse symposiums, enriched workshops, and B2B meetings.
 

Target Audience
Gastroenterologists
Hepatologists
Colorectal surgeons
Physician Assistants
Nurse Practitioners
Clinical Researchers & Scientists
Public Health Professionals
Pathologists
Medical Practitioners
Professors
General and acute medicine consultants and trainees
Gastro oncology nursing staff
Researchers
Scientists
Society for Gastrointestinal Oncology
AGA Institute Council Gastrointestinal Oncology Section (GIONC)
Surgeons
Radiologists
General scientists
Young investigators
Nurses
Pharmacists with an interest in GI oncology.

The benefit of the Association for Collaborators

Nobody in the world has such high levels of demand for medical treatment, making it the most straightforward platform for social commentary.
Creating long-lasting peer relationships.
Your organization's logo, branding and marketing materials, promotional content, and our webinar banner will all work to boost your subscriptions and members by 40%.
The association will be significantly impacted by the exposure of our event to your company's listing in the Global Business Forum.
The representatives can connect with important webinar attendees to update their knowledge and comprehension of your company and services.
Information will be included in gastrooncology prevention promotional materials such as posters, booklets, pamphlets, and services that will be sent to hospitals, universities, the general public, and researchers.

Market Analysis

Previous Conference Report

The “22nd World Congress on Gastrointestinal Cancer” was held on November 13-14, 2023, in the enchanting city of Dublin, Ireland. Renowned for its rich history and vibrant culture, Dublin provided an ideal backdrop for this significant gathering of medical professionals, researchers, and industry experts. The theme of this year’s conference, “Emerging Advances in Gastro Cancer,” highlighted the rapid progress being made in understanding and treating gastrointestinal cancers.

The conference featured a diverse array of presentations, panel discussions, and interactive sessions. Experts shared the latest research findings, clinical trial results, and innovative treatment approaches. Keynote speakers, including leading oncologists and researchers, presented groundbreaking work on targeted therapies, immunotherapies, and personalized medicine. These advancements are paving the way for more effective and less invasive treatment options for patients with gastrointestinal cancers.

One of the most notable sessions focused on the role of artificial intelligence in early diagnosis and treatment planning. AI-driven tools are improving accuracy in detecting cancer at earlier stages, thus significantly enhancing patient outcomes. Additionally, advancements in genomic profiling are allowing for more precise targeting of cancer cells, minimizing damage to healthy tissues and reducing side effects.

The conference also underscored the importance of a multidisciplinary approach in gastro cancer treatment. Collaboration among surgeons, medical oncologists, radiologists, and pathologists was emphasized as crucial for developing comprehensive and effective treatment plans. Furthermore, discussions on patient-centered care highlighted the need for psychological support and quality-of-life considerations in cancer treatment protocols.

Conclusion
The“22nd World Congress on Gastrointestinal Cancer” in Dublin was a resounding success. The theme, “Emerging Advances in Gastro Cancer,” encapsulated the dynamic and hopeful landscape of current gastro cancer research and treatment. The insights and knowledge shared at the conference will undoubtedly drive further innovations and improve patient care in the years to come.

Senior Manager
Gastro Cancer 2024
What's App: +447915641825 | General: 0044-2033180199
35 Ruddlesway, Windsor, Berkshire, SL4 5SF